---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-003487"
form_type: "8-K"
ticker: "OGEN"
cik: "0001174940"
company_name: "ORAGENICS INC"
filed_at: "2024-01-23T23:59:59+00:00"
generated_at: "2026-06-06T19:48:55.109676+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Oragenics terminates ATM equity offering program; had no sales under the agreement

## Summary
- Terminated ATM offering agreement with Ladenburg Thalmann effective January 30, 2024.
- No shares were sold and no proceeds were received under the program.
- Company is not subject to any termination penalties.

## SEC filing metadata
- accession: 0001493152-24-003487
- form_type: 8-K
- ticker: OGEN
- cik: 0001174940
- company_name: ORAGENICS INC
- filed_at: 2024-01-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 1.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1174940/000149315224003487/0001493152-24-003487-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1174940/000149315224003487/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-003487
- JSON: https://secwatch.observer/filing/0001493152-24-003487.json
- Plain text: https://secwatch.observer/filing/0001493152-24-003487.txt

## Key facts
- Material Agreements
  ORAGENICS INC terminated At the Market Offering Agreement with Ladenburg Thalmann & Co. Inc. (effective 2024-01-30).
  - Action: termination
  - Agreement: atm program
  - Counterparty: Ladenburg Thalmann & Co. Inc.
  - Effective: 2024-01-30
  source text: On January 23, 2024, Oragenics, Inc. (the “Company”), provided notice of its termination, effective January 30, 2024, of that certain At the Market Offering Agreement (the “Sales Agreement”) with Ladenburg Thalmann & Co. Inc. (“Ladenburg”) dated as of February 24, 2023 (the “Sales Agreement”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1174940/000149315224003487/0001493152-24-003487-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.